Clinical, laboratory data and inflammatory biomarkers at baseline as early discharge predictors in hospitalized SARS-CoV-2 infected patients
Year: 2022
Type: article
Study design: Observational Study
Abstract: BACKGROUND: The SARS-CoV-2 pandemic has overwhelmed hospital services due to the rapid transmission of the virus and its severity in a high percentage of cases. Having tools to predict which patients can be safely early discharged would help to improve this situation. METHODS: Patients confirmed as SARS-CoV-2 infection from four Spanish hospitals. Clinical, demographic, laboratory data and plasma samples were collected at admission. The patients were classified into mild and severe/critical groups according to 4-point ordinal categories based on oxygen therapy requirements. Logistic regression models were performed in mild patients with only clinical and routine laboratory parameters and adding plasma pro-inflammatory cytokine levels to predict both early discharge and worsening. RESULTS: 333 patients were included. At admission, 307 patients were classified as mild patients. Age, oxygen saturation, Lactate Dehydrogenase, D-dimers, neutrophil-lymphocyte ratio (NLR), and oral corticosteroids treatment were predictors of early discharge (area under curve (AUC), 0.786; sensitivity (SE) 68.5%; specificity (S), 74.5%; positive predictive value (PPV), 74.4%; and negative predictive value (NPV), 68.9%). When cytokines were included, lower interferon-γ-inducible protein 10 and higher Interleukin 1 beta levels were associated with early discharge (AUC, 0.819; SE, 91.7%; S, 56.6%; PPV, 69.3%; and NPV, 86.5%). The model to predict worsening included male sex, oxygen saturation, no corticosteroids treatment, C-reactive protein and Nod-like receptor as independent factors (AUC, 0.903; SE, 97.1%; S, 68.8%; PPV, 30.4%; and NPV, 99.4%). The model was slightly improved by including the determinations of interleukine-8, Macrophage inflammatory protein-1 beta and soluble IL-2Rα (CD25) (AUC, 0.952; SE, 97.1%; S, 98.1%; PPV, 82.7%; and NPV, 99.6%). CONCLUSIONS: Clinical and routine laboratory data at admission strongly predict non-worsening during the first two weeks; therefore, these variables could help identify those patients who do not need a long hospitalization and improve hospital overcrowding. Determination of pro-inflammatory cytokines moderately improves these predictive capacities.
Source: PLoS ONE
Authors: María Trujillo-Rodriguez, Esperanza Muñoz-Muela, Ana Serna-Gallego, Juan Manuel Praena-Fernández, Alberto Pérez-Gómez, Carmen Gasca-Capote, Joana Vitallé, Joaquim Peraire, Zaira R. Palacios-Baena, Jorge Julio Cabrera, Ezequiel Ruiz-Mateos, Eva Poveda, Luis Eduardo López-Cortés, Anna Rull, Alicia Gutierrez-Valencia, Luis Fernando López-Cortés
Institutions: Consejo Superior de Investigaciones Científicas, Instituto de Biomedicina de Sevilla, Hospital Universitario Virgen del Rocío, Universidad de Sevilla, Universidad de Granada, Instituto de Salud Carlos III, Institut de Recerca Biomèdica Catalunya Sud, Centro de Investigación Biomédica en Red, Hospital Universitari Joan XXIII de Tarragona, Centro de Investigación Biomédica en Red Enfermedades Infecciosas, Universitat Rovira i Virgili, Hospital Universitario Virgen Macarena, Servicio Gallego de Salud, Universidade de Vigo
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Keywords: SARS-CoV-2, COVID-19 pandemic, prognostic factors, inflammatory markers, inflammatory cytokines, neutrophil-to-lymphocyte ratio, D-dimer, lactate dehydrogenase, C-reactive protein, CXCL10, IL-1β, interleukin-8, macrophage inflammatory protein-1β, soluble IL-2 receptor alpha, NOD-like receptors, corticosteroid therapy, disease worsening
Open Access status: gold
Estimated APC paid: $1,805
OpenAlex ID: W4285387124
